Publicacións en colaboración con investigadores/as de Statens Serum Institut (13)

2024

  1. Genome-wide Association Study of Susceptibility to Respiratory Syncytial Virus Hospitalization in Young Children <5 Years of age

    Journal of Infectious Diseases, Vol. 230, Núm. 2, pp. e333-e341

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis

    Journal of Infectious Diseases, Vol. 226, pp. S29-S37

  2. Global Disease Burden of Respiratory Syncytial Virus in Preterm Children in 2019: A Systematic Review and Individual Participant Data Meta-Analysis Protocol

    Journal of Infectious Diseases, Vol. 226, pp. S135-S141

  3. Patient Involvement in RSV Research: Towards Patients Setting the Research Agenda

    Journal of Infectious Diseases, Vol. 226, pp. S130-S134

  4. Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials

    Journal of Clinical Epidemiology, Vol. 147, pp. 11-20

2021

  1. Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus

    Nature Communications, Vol. 12, Núm. 1

  2. Global and regional burden of hospital admissions for pneumonia in older adults: A systematic review and meta-analysis

    Journal of Infectious Diseases, Vol. 222, pp. S570-S576

  3. Immunological and inflammatory biomarkers of susceptibility and severity in adult respiratory syncytial virus infections

    Journal of Infectious Diseases, Vol. 222, pp. S584-S591

  4. Publisher Correction: Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus (Nature Communications, (2021), 12, 1, (5125), 10.1038/s41467-021-25265-4)

    Nature Communications

2016

  1. Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe

    Clinical Infectious Diseases, Vol. 62, Núm. 5, pp. 655-663

2011

  1. Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

    Genetics in Medicine, Vol. 13, Núm. 3, pp. 230-254

  2. Common variants at VRK2 and TCF4 conferring risk of schizophrenia

    Human Molecular Genetics, Vol. 20, Núm. 20, pp. 4076-4081